| 000 | 00924 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250517030438.0 | ||
| 264 | 0 | _c20150914 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/leu.2015.93 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIp, H-W | |
| 245 | 0 | 0 |
_aDeep molecular response in chronic myelogenous leukemia: ensuring accuracy and consistency. _h[electronic resource] |
| 260 |
_bLeukemia _cJul 2015 |
||
| 300 |
_a1620-1 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aGene Expression Regulation, Leukemic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xmetabolism |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 700 | 1 | _aSo, C-C | |
| 773 | 0 |
_tLeukemia _gvol. 29 _gno. 7 _gp. 1620-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2015.93 _zAvailable from publisher's website |
| 999 |
_c24837102 _d24837102 |
||